For example, there has been an increase in UBE2C levels in various types of cancer (e.g. breast cancer, esophageal squamous cell carcinoma, and lung cancer), and its overexpression correlates with poor prognosis in patients [25–27]. This evidence concerns the gene UBE2C and breast carcinoma.